Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Baltimore

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
RNA (New York, N.Y.)|November 20, 2019
Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activityLuke Frankiw, Mati Mann, Guideng Li, et al.
Molecular and Cellular Biology|May 2, 2003
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaksMatthew H Porteus, Toni Cathomen, Matthew D Weitzman, et al.
The Journal of Biological Chemistry|July 18, 2012
EHMT1 protein binds to nuclear factor-κB p50 and represses gene expressionChee-Kwee Ea, ShengLi Hao, Kok Siong Yeo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-toleranceAndrey Antov, Lili Yang, Monika Vig, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2006
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesKonstantin D Taganov, Mark P Boldin, Kuang-Jung Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2009
Inositol phosphatase SHIP1 is a primary target of miR-155Ryan M O'Connell, Aadel A Chaudhuri, Dinesh S Rao, et al.
Pigment Cell & Melanoma Research|January 14, 2010
Overcoming barriers to programming a therapeutic cellular immune response to fight melanomaDavid Baltimore, Owen N Witte, Lili Yang, et al.
Biochemistry|June 12, 2002
Inhibition of DNA binding by NF-kappa B with pyrrole-imidazole polyamidesNicholas R Wurtz, Joel L Pomerantz, David Baltimore, et al.
Science (New York, N.Y.)|September 17, 2005
Achieving stability of lipopolysaccharide-induced NF-kappaB activationMarkus W Covert, Thomas H Leung, Jahlionais E Gaston, et al.
Nature Reviews. Immunology|January 26, 2010
Physiological and pathological roles for microRNAs in the immune systemRyan M O'Connell, Dinesh S Rao, Aadel A Chaudhuri, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
RNA (New York, N.Y.)|November 20, 2019
Alternative splicing coupled with transcript degradation modulates OAS1g antiviral activityLuke Frankiw, Mati Mann, Guideng Li, et al.
Molecular and Cellular Biology|May 2, 2003
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaksMatthew H Porteus, Toni Cathomen, Matthew D Weitzman, et al.
The Journal of Biological Chemistry|July 18, 2012
EHMT1 protein binds to nuclear factor-κB p50 and represses gene expressionChee-Kwee Ea, ShengLi Hao, Kok Siong Yeo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 23, 2003
Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-toleranceAndrey Antov, Lili Yang, Monika Vig, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2006
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responsesKonstantin D Taganov, Mark P Boldin, Kuang-Jung Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2009
Inositol phosphatase SHIP1 is a primary target of miR-155Ryan M O'Connell, Aadel A Chaudhuri, Dinesh S Rao, et al.
Pigment Cell & Melanoma Research|January 14, 2010
Overcoming barriers to programming a therapeutic cellular immune response to fight melanomaDavid Baltimore, Owen N Witte, Lili Yang, et al.
Biochemistry|June 12, 2002
Inhibition of DNA binding by NF-kappa B with pyrrole-imidazole polyamidesNicholas R Wurtz, Joel L Pomerantz, David Baltimore, et al.
Science (New York, N.Y.)|September 17, 2005
Achieving stability of lipopolysaccharide-induced NF-kappaB activationMarkus W Covert, Thomas H Leung, Jahlionais E Gaston, et al.
Nature Reviews. Immunology|January 26, 2010
Physiological and pathological roles for microRNAs in the immune systemRyan M O'Connell, Dinesh S Rao, Aadel A Chaudhuri, et al.
Pageof 18